natgillin/translations-raw huggingface dataset:
PegIntron leveres i forskellige pakningsstørrelser: - 1 fyldt pen indeholdende pulver og solvens til injektionsvæske, opløsning, 1 kanyle (”Push-on 
PegIntron is available in different pack sizes: - 1 pre-filled pen containing powder and solvent for solution for injection, 1 needle ("Push-On Needle"),
PegIntron er til 20 μg/m 2/uge. 
nd dose reduction of PegIntron is to 20 g/m 2/week.
Genotype 2 eller 3: 
• Genotype 2 or 3:
Tidligere respons Recidiv 
Sustained response
Karton 120 mikrogram 
Carton 120 micrograms
Tabel 6 Bivirkninger, der er rapporteret hos voksne i kliniske forsøg eller efter markedsføring, hos patienter behandlet med peginterferon alfa-2b, inklusive PegIntron-monoterapi eller PegIntron + ribavirin 
Table 6 Adverse reactions reported in adults in clinical trials or through post-marketing surveillance in patients treated with peginterferon alfa-2b, including PegIntron monotherapy or PegIntron + ribavirin
• aplastisk anæmi, slagtilfælde (blodprop i hjernen eller hjerneblødning hændelser), toksisk epidermal nekrolyse/Stevens-Johnsons syndrom/erythema multiforme (et spektrum af udslæt af varierende sværhedsgrad inklusive dødsfald, som kan være forbundet med blister i mund, næse, øjne og andre slimhindemembraner og afstødning af det berørte område af huden). 
Very rare side effects (may affect up to 1 in 10,000 people): - aplastic anaemia, stroke (cerebrovascular events), toxic epidermal necrolysis/Stevens Johnson Syndrome/erythema multiforme (a spectrum of rashes with varying degree of severity including death which may be associated with blisters in the mouth, nose, eyes and other mucosal membranes and sloughing of the affected area of the skin).
• smagsforandringer, diarré, maveonde, mundsmerter, 
- changes in taste, diarrhoea, stomach upset, oral pain,
Needle”), 2 renseservietter; - 4 fyldte penne indeholdende pulver og solvens til injektionsvæske, opløsning, 4 kanyler (”Push on Needle”), 8 renseservietter; 
2 cleansing swabs; - 4 pre-filled pens containing powder and solvent for solution for injection, 4 needles ("Push-On Needle"),
PegIntron styrke (g/0,5 ml) 
PegIntron strength (g/0.5 ml)
- 4 hætteglas pulver til injektionsvæske, opløsning, 4 ampuller solvens til injektion, 4 injektionssprøjter, 8 kanyler og 4 renseservietter; - 6 hætteglas pulver til injektionsvæske, opløsning og 6 ampuller solvens til injektion; - 12 hætteglas pulver til injektionsvæske, opløsning, 12 ampuller solvens til injektion, 12 injektionssprøjter, 24 kanyler og 12 renseservietter. 
2 injection needles and 1 cleansing swab; - 4 vials of powder for solution for injection and 4 ampoules of solvent for injection; - 4 vials of powder for solution for injection, 4 ampoules of solvent for injection, 4 injection syringes, 8 injection needles and 4 cleansing swabs; - 6 vials of powder for solution for injection and 6 ampoules of solvent for injection; - 12 vials of powder for solution for injection, 12 ampoules of solvent for injection, 12 injection syringes, 24 injection needles and 12 cleansing swabs.
• Hvis dette lægemiddel tages i kombination med ribavirin og et eller flere anti-hiv-lægemiddel(ler) kan risikoen øges for mælkesyreacidose, leversvigt og udvikling af blodabnormiteter: reduktion i antallet af røde blodlegemer, hvide blodlegemer og blodkoagulerende celler kaldet blodplader. 
o Taking this medicine in combination with ribavirin and an anti-HIV medicine(s) may increase the risk of lactic acidosis, liver failure, and blood abnormalities: reduction in number of red blood cells, white blood cells and blood clotting cells called platelets.
Der henvises til indlægssedlen for theophyllin, når det administreres sammen med PegIntron. 
Package inserts of theophylline should be referred to when co-administering with the product (PegIntron)
• nedsat antal røde blodlegemer som kan skabe træthed, åndenød, svimmelhed. 
decrease in rate of growth (height and weight for age), - decreases in red blood cells that may cause fatigue, shortness of breath, dizziness.
PegIntron 120 mikrog 
PegIntron 120 mcg
• Stik kanylen gennem gummimembranen på PegIntron hætteglasset og placer forsigtigt kanylespidsen mod glasvæggen i hætteglasset uden at røre den rensede membran på hætteglasset med hænderne. 
Gently place the needle tip against the glass wall of the vial without touching the cleaned top of the vial with your hands.
Hos 12 % (23/194) af patienterne, der blev behandlet med PegIntron i kombination med ribavirin, blev der rapporteret om anæmi (hæmoglobin < 9,4 g/dl). 
Anaemia (hemoglobin < 9.4 g/dl) was reported in 12 % (23/194) of patients treated with PegIntron in combination with ribavirin.
Doser til patienter, der ordineres 0,5 g/kg/uge, skal således justeres ved volumen, som vist i Tabel2. 
The lowest PegIntron strength available is 50 g/0.5 ml; therefore for patients prescribed 0.5 g/kg/week, doses must be adjusted by volume as shown in Table 2.
PegIntron 150 mikrog 
PegIntron 150 mcg
PegIntron leveres i forskellige pakningsstørrelser: - 1 hætteglas pulver til injektionsvæske, opløsning og 1 ampul solvens til injektion; - 1 hætteglas pulver til injektionsvæske, opløsning, 1 ampul solvens til injektion, 1 injektionssprøjte, 2 kanyler og 1 renseserviet; - 4 hætteglas pulver til injektionsvæske, opløsning og 4 ampuller solvens til injektion; 
PegIntron is available in different pack sizes: - 1 vial of powder for solution for injection and 1 ampoule of solvent for injection; - 1 vial of powder for solution for injection, 1 ampoule of solvent for injection, 1 injection syringe,
Hver fyldt pen indeholder derfor en ekstra mængde solvens og PegIntron-pulver for at sikre indgift af den anførte dosis i 0,5 ml PegIntron injektionsvæske, opløsning. 
Therefore, each pre-filled pen contains an excess amount of solvent and PegIntron powder to ensure delivery of the labelled dose in 0.5 ml of PegIntron, solution for injection.
For bortskaffelse, se punkt 5 "Opbevaring". 
For disposal instructions, see section 5 “How to store PegIntron”.
Der henvises til indlægssedlen for thioridazin, når det administreres sammen med PegIntron. 
Package inserts of thioridazine should be referred to when co-administering with the product (PegIntron)
Mængde PegIntron, der skal indgives (g) 
Amount of PegIntron to administer (g)
PegIntron 100 mikrog 
PegIntron 100 mcg
PegIntron 50 mikrog 
PegIntron 50 mcg
- PegIntron (1,5 mikrogram/kg/uge i en måned efterfulgt af 0,5 mikrogram/kg/uge i 11 måneder) + ribavirin (1.000/1.200 mg/dag), (n = 514). 
- PegIntron (1.5 micrograms/kg/week for one month followed by 0.5 microgram/kg/week for
PegIntron 80 mikrog 
PegIntron 80 mcg
Sådan skal du tage PegIntron 
How to use PegIntron
Hos børn og unge reduceres PegIntron 1. gang til 40 μg/m2/uge, 2. dosisreduktion af 
st dose reduction of PegIntron is to 40 g/m 2/week, 2
Det skal du vide, før du begynder at tage PegIntron Sådan skal du tage PegIntron Bivirkninger 
What PegIntron is and what it is used for What you need to know before you use PegIntron How to use PegIntron
2. dosisreduktion af PegIntron er til 0,5 μg/kg/uge, hvis det er nødvendigt. 
nd dose reduction of PegIntron is to 0.5 µg/kg/week.
Hvert hætteglas indeholder derfor en ekstra mængde solvens og PegIntron pulver for at sikre indgift af den anførte dosis i 0,5 ml PegIntron, injektionsvæske. 
Therefore, each vial contains an extra amount of solvent and PegIntron powder to ensure delivery of the labeled dose in 0.5 ml of PegIntron, solution for injection.
Mængden af PegIntron, der skal administrere s (µg) 
Amount of PegIntron to administer (µg)
Kontakt lægen eller apotekspersonalet for dig eller barnet, du har ansvar for, hvis der er noget, du er i tvivl om. 
If you are uncertain, contact your doctor or pharmacist or the doctor or pharmacist of the child you are caring for.
PegIntron 120 mikrogram pulver og solvens til injektionsvæske, opløsning EU/1/00/131/016 
PegIntron 120 micrograms powder and solvent for solution for injection EU/1/00/131/016
PegIntron 120 mikrogram - hætteglas med pulver 
PegIntron 120 micrograms - vial of powder
PegIntron 80 mikrogram pulver og solvens til injektionsvæske, opløsning EU/1/00/131/006 
PegIntron 80 micrograms powder and solvent for solution for injection EU/1/00/131/006
PegIntron 150 mikrogram - hætteglas med pulver 
PegIntron 150 micrograms - vial of powder
Sjældne bivirkninger (kan berøre op til 1 ud af 1.000 personer): - diabetisk ketoacidose (en medicinsk nødsituation, hvor et forhøjet niveau af ketonstoffer i blodet opstår som et resultat af, at diabetes er ude af kontrol), - anfald (kramper) og bipolare lidelser (humørsvingninger karakteriseret ved vekslende episoder af tungsind og begejstring), - øjenproblemer herunder ændringer i synet, beskadigelse af nethinden, obstruktion af nethindearterien, betændelse i synsnerven, hævelse af øjet, 
Rare side effects (may affect up to 1 in 1,000 people): - diabetic ketoacidosis (medical emergency due to build-up of ketone bodies in the blood as a result of out-of-control diabetes), - seizures (convulsions) and bipolar disorders (mood disorders characterized by alternating episodes of sadness and excitement), - eye problems including changes in vision, damage to the retina, obstruction of the retinal artery, inflammation of the optic nerve, swelling of the eye, - congestive heart failure, abnormal heart rhythm, pericarditis (inflammation of the lining of the heart), inflammation and degeneration of muscle tissue and peripheral nerves, kidney problems, - sarcoidosis (a disease characterized by persistent fever, weight loss, joint pain and swelling, skin lesions and swollen glands).
Fortæl det altid til lægen eller på apoteket, hvis du eller barnet, du har ansvar for: 
Tell your doctor or healthcare professional or the doctor or healthcare professional of the child you are caring for as soon as possible.
PegIntron 150 mikrogram pulver og solvens til injektionsvæske, opløsning EU/1/00/131/021 
PegIntron 150 micrograms powder and solvent for solution for injection EU/1/00/131/021
PegIntron 50 mikrogram pulver og solvens til injektionsvæske, opløsning EU/1/00/131/001 
PegIntron 50 micrograms powder and solvent for solution for injection EU/1/00/131/001
PegIntron 80 mikrogram - hætteglas med pulver 
PegIntron 80 micrograms - vial of powder
9/l, og <70 x 
9/l, and < 50 x 10
• irritabilitet, træthed, utilpashed, smerte, kulderystelser, feber, influenzalignende symptomer, 
*, injection site inflammation, fatigue, asthenia, irritability, chills, pyrexia, influenza like illness, pain
PegIntron 50 mikrogram - hætteglas med pulver 
PegIntron 50 micrograms - vial of powder
PegIntron 100 mikrogram pulver og solvens til injektionsvæske, opløsning EU/1/00/131/011 
PegIntron 100 micrograms powder and solvent for solution for injection EU/1/00/131/011
PegIntron 150 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen EU/1/00/131/047 
PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/047
Karton 80 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen 
Carton 80 micrograms powder and solvent for solution for injection in pre-filled pen
PegIntron 120 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen EU/1/00/131/043 
PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/043
PegIntron 100 mikrogram - hætteglas med pulver 
PegIntron 100 micrograms - vial of powder
PegIntron 80 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen EU/1/00/131/035 
PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/035
Note 2: Hos voksne patienter er 1. dosisreduktion af PegIntron til 1 μg/kg/uge. 
st dose reduction of PegIntron is to 1 µg/kg/week.
PegIntron volume, der skal indgives (ml) 
Volume of PegIntron to Administer (ml)
PegIntron 50 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen EU/1/00/131/031 
PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/031
• Spørg lægen eller apotekspersonalet, hvis der er mere du vil vide. 
Check with your doctor or pharmacist if you are not sure.
Label til pen - PegIntron 120 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen 
Pen label - PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen
PegIntron 100 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen EU/1/00/131/039 
PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen EU/1/00/131/039
PegIntron 80 mikrogram pulver og solvens til injektionsvæske, opløsning Hvert hætteglas skal rekonstitueres med 0,7 ml vand til injektionsvæsker for indgift af op til 0,5 ml opløsning. 
PegIntron 80 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
• rygsmerter, muskel- og knoglesmerter, smerter i lemmerne, tørhed, smerter, udslæt, irritation eller kløe ved indsprøjtningsstedet. 
eczema (inflamed, red, itchy and dryness of the skin with possible oozing lesions), acne, - back pain, muscle and bone pain, limb pain, dryness, pain, rash, irritation or itching at the site of injection.
Label til pen - PegIntron 150 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen 
Pen label - PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen
PegIntron 80 mikrogram pulver til injektionsvæske peginterferon alfa-2b s.c. 
PegIntron 80 micrograms powder for injection peginterferon alfa-2b
PegIntron 50 mikrogram pulver og solvens til injektionsvæske, opløsning PegIntron 80 mikrogram pulver og solvens til injektionsvæske, opløsning PegIntron 100 mikrogram pulver og solvens til injektionsvæske, opløsning PegIntron 120 mikrogram pulver og solvens til injektionsvæske, opløsning PegIntron 150 mikrogram pulver og solvens til injektionsvæske, opløsning peginterferon alfa-2b 
PegIntron 50 micrograms powder and solvent for solution for injection PegIntron 80 micrograms powder and solvent for solution for injection PegIntron 100 micrograms powder and solvent for solution for injection PegIntron 120 micrograms powder and solvent for solution for injection PegIntron 150 micrograms powder and solvent for solution for injection peginterferon alfa-2b
Patienter, der er i kombinationsbehandling med PegIntron og ribavirin og zidovudin, har en øget risiko for at udvikle anæmi. 
Patients treated with PegIntron and ribavirin combination therapy and zidovudine are at increased risk of developing anaemia and therefore the concomitant use of this combination with zidovudine is not recommended (see section 4.5).
Brug af anden medicin sammen med PegIntron Fortæl det altid til lægen eller på apoteket, hvis du eller barnet, du har ansvar for: 
Other medicines and PegIntron Please tell your doctor or pharmacist if you, or the child you are caring for: - are taking or have recently taken any other medicines or vitamins/nutritional supplements, including medicines obtained without a prescription.
PegIntron volumen, der skal indgives (ml) 
Volume of PegIntron to administer (ml)
EU/1/00/131/047 (1 pen, 1 kanyle og 2 renseservietter) EU/1/00/131/048 (4 penne, 4 kanyler og 8 renseservietter) EU/1/00/131/050 (12 penne, 12 kanyler og 24 renseservietter) 
EU/1/00/131/047 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/048 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/050 (12 pens, 12 injection needles and 24 cleansing swabs)
PegIntron 80 mikrogram pulver og solvens til injektionsvæske peginterferon alfa-2b 
PegIntron 80 micrograms powder and solvent for injection peginterferon alfa-2b
PegIntron 120 mikrogram pulver til injektionsvæske peginterferon alfa-2b s.c. 
PegIntron 120 micrograms powder for injection peginterferon alfa-2b
EU/1/00/131/039 (1 pen, 1 kanyle og 2 renseservietter) EU/1/00/131/040 (4 penne, 4 kanyler og 8 renseservietter) EU/1/00/131/042 (12 penne, 12 kanyler og 24 renseservietter) 
EU/1/00/131/039 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/040 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/042 (12 pens, 12 injection needles and 24 cleansing swabs)
EU/1/00/131/008 (4 hætteglas med pulver, 4 ampuller med solvens) EU/1/00/131/009 (4 hætteglas med pulver, 4 ampuller med solvens, 4 injektionssprøjter, 8 kanyler og 4 renseservietter) 
EU/1/00/131/008 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/009 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
EU/1/00/131/043 (1 pen, 1 kanyle og 2 renseservietter) EU/1/00/131/044 (4 penne, 4 kanyler og 8 renseservietter) EU/1/00/131/046 (12 penne, 12 kanyler og 24 renseservietter) 
EU/1/00/131/043 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/044 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/046 (12 pens, 12 injection needles and 24 cleansing swabs)
EU/1/00/131/016 (1 hætteglas med pulver, 1 ampul med solvens) EU/1/00/131/017 (1 hætteglas med pulver, 1 ampul med solvens, 1 injektionssprøjte, 2 kanyler og 1 renseserviet) 
EU/1/00/131/016 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/017 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
PegIntron 120 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen Hver fyldt pen indeholder 120 mikrogram peginterferon alfa-2b målt på proteinbasis. 
PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen Each pre-filled pen contains 120 micrograms of peginterferon alfa-2b measured on a protein basis.
PegIntron 120 mikrogram pulver og solvens til injektionsvæske, opløsning Hvert hætteglas skal rekonstitueres med 0,7 ml vand til injektionsvæsker for indgift af op til 0,5 ml opløsning. 
PegIntron 120 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
Label til pen - PegIntron 100 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen 
Pen label - PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen
Label til pen - PegIntron 80 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen 
Pen label - PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen
EU/1/00/131/006 (1 hætteglas med pulver, 1 ampul med solvens) EU/1/00/131/007 (1 hætteglas med pulver, 1 ampul med solvens, 1 injektionssprøjte, 2 kanyler og 1 renseserviet) 
EU/1/00/131/006 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/007 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
EU/1/00/131/011 (1 hætteglas med pulver, 1 ampul med solvens) EU/1/00/131/012 (1 hætteglas med pulver, 1 ampul med solvens, 1 injektionssprøjte, 2 kanyler og 1 renseserviet) 
EU/1/00/131/011 (1 vial of powder, 1 ampoule of solvent) EU/1/00/131/012 (1 vial of powder, 1 ampoule of solvent, 1 injection syringe, 2 injection needles and 1 cleansing swab)
Hvert hætteglas giver 150 mikrogram/0,5 ml opløsning, når det er rekonstitueret som anbefalet. 
Each vial provides 150 micrograms/0.5 ml of solution when reconstituted as recommended
Label til pen - PegIntron 50 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen 
Pen label - PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen
EU/1/00/131/020 (6 hætteglas med pulver, 6 ampuller med solvens) EU/1/00/131/029 (12 hætteglas med pulver, 12 ampuller med solvens, 12 injektionssprøjter, 24 kanyler og 12 renseservietter) 
EU/1/00/131/020 (6 vials of powder, 6 ampoules of solvent) EU/1/00/131/029 (12 vials of powder, 12 ampoules of solvent, 12 injection syringes, 24 injection needles and 12 cleansing swabs)
PegIntron 50 mikrogram pulver til injektionsvæske peginterferon alfa-2b s.c. 
PegIntron 50 micrograms powder for injection peginterferon alfa-2b
PegIntron 150 mikrogram pulver til injektionsvæske peginterferon alfa-2b s.c. 
PegIntron 150 micrograms powder for injection peginterferon alfa-2b
PegIntron 50 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen PegIntron 80 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen PegIntron 100 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen PegIntron 120 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen PegIntron 150 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen peginterferon alfa-2b 
PegIntron 50 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 80 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 100 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 120 micrograms powder and solvent for solution for injection in pre-filled pen PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen peginterferon alfa-2b
PegIntron 150 mikrogram pulver og solvens til injektionsvæske, opløsning Hvert hætteglas skal rekonstitueres med 0,7 ml vand til injektionsvæsker for indgift af op til 0,5 ml opløsning. 
PegIntron 150 micrograms powder and solvent for solution for injection Each vial is to be reconstituted with 0.7 ml of water for injections for administration of up to 0.5 ml of solution.
EU/1/00/131/023 (4 hætteglas med pulver, 4 ampuller med solvens) EU/1/00/131/024 (4 hætteglas med pulver, 4 ampuller med solvens, 4 injektionssprøjter, 8 kanyler og 4 renseservietter) 
EU/1/00/131/023 (4 vials of powder, 4 ampoules of solvent) EU/1/00/131/024 (4 vials of powder, 4 ampoules of solvent, 4 injection syringes, 8 injection needles and 4 cleansing swabs)
PegIntron 120 mikrogram pulver og solvens til injektionsvæske peginterferon alfa-2b 
PegIntron 120 micrograms powder and solvent for injection peginterferon alfa-2b
EU/1/00/131/035 (1 pen, 1 kanyle og 2 renseservietter) EU/1/00/131/036 (4 penne, 4 kanyler og 8 renseservietter) EU/1/00/131/038 (12 penne, 12 kanyler og 24 renseservietter) 
EU/1/00/131/035 (1 pen, 1 injection needle and 2 cleansing swabs) EU/1/00/131/036 (4 pens, 4 injection needles and 8 cleansing swabs) EU/1/00/131/038 (12 pens, 12 injection needles and 24 cleansing swabs)
Meget almindelige bivirkninger (kan berøre flere end 1 ud af 10 personer): - depressionsfølelse, irritabilitet, besvær med at falde i søvn eller sove igennem, følelse af angst eller nervøsitet, koncentrationsbesvær, humørsvingninger, 
Very common side effects (may affect more than 1 in 10 people): breathing problems (including shortness of breath), feeling depressed, trouble sleeping, thinking or concentrating, dizziness, severe stomach pain or cramps, fever or chills beginning after a few weeks of treatment, painful or inflamed muscles (sometimes severe),
PegIntron 100 mikrogram pulver til injektionsvæske peginterferon alfa-2b s.c. 
PegIntron 100 micrograms powder for injection peginterferon alfa-2b
PegIntron 150 mikrogram pulver og solvens til injektionsvæske, opløsning i fyldt pen Hver fyldt pen indeholder 150 mikrogram peginterferon alfa-2b målt på proteinbasis. 
PegIntron 150 micrograms powder and solvent for solution for injection in pre-filled pen Each pre-filled pen contains 150 micrograms of peginterferon alfa-2b measured on a protein basis.
PegIntron 50 mikrogram pulver og solvens til injektionsvæske peginterferon alfa-2b 
PegIntron 50 micrograms powder and solvent for injection peginterferon alfa-2b
PegIntron 80 mikrogram pulver og solvens til injektionsvæske, opløsning Hvert hætteglas indeholder 80 mikrogram peginterferon alfa-2b målt på proteinbasis. 
PegIntron 80 micrograms powder and solvent for solution for injection Each vial contains 80 micrograms of peginterferon alfa-2b measured on a protein basis.